Atherosclerosis and Hyperlipidemia

Articles

Lipoprotein(a): A Risk Factor and Biomarker in Heart Failure

Published:

20 April 2026

Citation:

Cardiac Failure Review 2026;12:e07.

Sphingomyelin and Cardiovascular Implications

Citation:

European Cardiology Review 2018;13(1):42–5.

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Citation:

European Cardiology Review 2017;12(2):96.

Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy

Citation:

European Cardiology Review 2017;12(2):88